Literature DB >> 19751283

Comparative effectiveness research in Ontario, Canada: producing relevant and timely information for health care decision makers.

Danielle M Whicher1, Kalipso Chalkidou, Irfan A Dhalla, Leslie Levin, Sean Tunis.   

Abstract

CONTEXT: Comparative effectiveness research is increasingly being recognized as a method to link research with the information needs of decision makers. As the United States begins to invest in comparative effectiveness, it would be wise to look at other functioning research networks to understand the infrastructure and funding required to support them.
METHODS: This case study looks at the comparative effectiveness research network in Ontario, Canada, for which a neutral coordinating committee is responsible for prioritizing topics, assessing evidence, providing recommendations on coverage decisions, and determining pertinent research questions for further evaluation. This committee is supported by the Medical Advisory Secretariat and several large research institutions. This article analyzes the infrastructure and cost needed to support this network and offers recommendations for developing policies and methodologies to support comparative effectiveness research in the United States.
FINDINGS: The research network in place in Ontario explicitly links decision making with evidence generation, in a transparent, timely, and efficient way. Funding is provided by the Ontario government through a reliable and stable funding mechanism that helps ensure that the studies it supports are relevant to decision makers.
CONCLUSIONS: With the recent allocation of funds to support comparative effectiveness research from the American Recovery and Reinvestment Act, the United States should begin to construct an infrastructure that applies these features to make sure that evidence generated from this effort positively affects the quality of health care delivered to patients.

Entities:  

Mesh:

Year:  2009        PMID: 19751283      PMCID: PMC2881460          DOI: 10.1111/j.1468-0009.2009.00572.x

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


  8 in total

1.  Revisiting the Canadian health care system.

Authors:  J K Iglehart
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

2.  The future of health care in Canada.

Authors:  S Lewis; C Donaldson; C Mitton; G Currie
Journal:  BMJ       Date:  2001-10-20

3.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

Authors:  Sean R Tunis; Daniel B Stryer; Carolyn M Clancy
Journal:  JAMA       Date:  2003-09-24       Impact factor: 56.272

4.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

5.  Coverage options for promising technologies: Medicare's 'coverage with evidence development'.

Authors:  Sean R Tunis; Steven D Pearson
Journal:  Health Aff (Millwood)       Date:  2006 Sep-Oct       Impact factor: 6.301

Review 6.  Building bridges between academic research and policy formulation: the PRUFE framework - an integral part of Ontario's evidence-based HTPA process.

Authors:  Ron Goeree; Leslie Levin
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: the Ontario experience.

Authors:  Leslie Levin; Ron Goeree; Nancy Sikich; Birthe Jorgensen; Melissa C Brouwers; Tony Easty; Catherine Zahn
Journal:  Int J Technol Assess Health Care       Date:  2007       Impact factor: 2.188

8.  Effectiveness and safety of drug-eluting stents in Ontario.

Authors:  Jack V Tu; James Bowen; Maria Chiu; Dennis T Ko; Peter C Austin; Yaohua He; Robert Hopkins; Jean-Eric Tarride; Gord Blackhouse; Charles Lazzam; Eric A Cohen; Ron Goeree
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

  8 in total
  3 in total

Review 1.  International comparison of comparative effectiveness research in five jurisdictions: insights for the US.

Authors:  Adrian R Levy; Craig Mitton; Karissa M Johnston; Brian Harrigan; Andrew H Briggs
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Understanding the value of information from pediatric clinical research.

Authors:  Wendy J Ungar
Journal:  Paediatr Drugs       Date:  2012-10-01       Impact factor: 3.022

Review 3.  Does the engagement of clinicians and organisations in research improve healthcare performance: a three-stage review.

Authors:  Annette Boaz; Stephen Hanney; Teresa Jones; Bryony Soper
Journal:  BMJ Open       Date:  2015-12-09       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.